Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 3Neutropenia 1Myelodysplastic Syndromes 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Filgrastim 7plerixafor 2Etoposide 2Cyclosporine 2Cyclophosphamide 2pegfilgrastim 1ixabepilone 1Voriconazole 1Vincristine 1Tretinoin 1Topotecan 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1Phenobarbital 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Levofloxacin 1Lenalidomide 1Irinotecan 1Ifosfamide 1Idarubicin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Daunorubicin 1Cytarabine 1Clofarabine 1Ciprofloxacin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neutropenia × Amsacrine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡